J&J CEO on the Quest to Cure Cancer
At the 2026 WSJ CEO Council Summit in London, Johnson & Johnson Chairman and CEO Joaquin Duato explains why he believes some cancers could eventually be cured, while others may become manageable chronic diseases. He also discusses breakthroughs in immunotherapy and other treatments that are already transforming outcomes for patients. Photo: Anne Moffat for the WSJ Leadership Institute
1:54
WSJ Leadership Institute Presents: Leaders
The WSJ Leadership Institute Presents: Leaders. A new podcast series bringing you revealing conversations with top executives shaping business today. Hosted by Alan Murray, president of the WSJ Leadership Institute, the series goes beyond headlines to explore how leadership really works in times of upheaval, transformation, and uncertainty. Our first episode was released Monday, Sept. 22, at 5:00 a.m. ET, with new episodes every other Monday.